entrezID,gene_symbol,biotype,bioproject,res_design,host_type,stimulator,concentration,H.P.S,baseMean,log2FoldChange,lfcSE,stat,pvalue,padj,cell_type
100874214,TM4SF19-AS1,lncRNA,PRJNA474093,IFN-beta stimulation vs. mock stimulation,immortalized human hepatocytes PH5CH8,IFN-beta,N.A.,12,16.7875394757975,-0.057289669287431,0.503427119396777,-0.113799330787101,0.909396869102371,0.994998021163286,NA
100874214,TM4SF19-AS1,lncRNA,PRJNA565586,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,100U/ml,24,8.07629441613004,-0.0808189580886694,0.649291085277562,-0.124472613164126,0.900941083253328,0.991845843761046,patient-derived GBM cell lines (PDGCLs)
100874214,TM4SF19-AS1,lncRNA,PRJNA667475,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,250U/ml,8,15.980061486258,-0.471143058570548,0.531263701290433,-0.886834649960364,0.375167929482869,0.79186346122024,A549
100874214,TM4SF19-AS1,lncRNA,PRJNA739760,INF-alpha2 stimulation (with DMSO) vs. mock stimulation (with DMSO),NA,IFN-alpha,1000U/ml,16,20.3090274677102,-0.16486035973255,0.433335750818528,-0.380444861567839,0.7036152188794,0.986418245486816,A549
100874214,TM4SF19-AS1,lncRNA,PRJNA768480,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,N.A.,N.A.,10.1466278144494,1.40116179639936,1.02869492287713,1.36207709908832,0.173173554741052,0.388647602831666,A549
100874214,TM4SF19-AS1,lncRNA,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,2.93159464841319,-1.49383212432124,1.10053536114522,-1.35736858356532,0.174664125358883,1,sigmoid colon organoid
100874214,TM4SF19-AS1,lncRNA,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,2.93159464841319,-0.071245306519934,0.936790141269338,-0.0760525793145064,0.93937726704306,1,sigmoid colon organoid
